Biotechnology

4 posts

Kiran Mazumdar-Shaw’s Bold Healthcare Mission – Asrar Qureshi’s Blog Post #1203

Asrar Qureshi’s blog post highlights Kiran Mazumdar-Shaw’s transformative journey with Biocon, emphasizing her mission-driven leadership in biotechnology. She advocates for affordable, accessible healthcare and resilient innovation, turning challenges into opportunities. Mazumdar-Shaw’s insights stress the importance of purpose, collaboration, and ecosystem development in creating impactful healthcare solutions for emerging markets.
Share
View Post
  • 5 min

New Drug Modalities – Asrar Qureshi’s Blog Post 1047

Asrar Qureshi’s blog discusses the Boston Consulting Group’s second annual report on the growth of new drug modalities. It highlights advancements in antibodies, recombinant products, cell therapies, gene therapies, and mRNA applications, emphasizing their implications for biopharma companies and patient care. The future of these modalities depends on their unique benefits and market speed.
Share
View Post
  • 6 min

Expected Changes for Contract Research Organizations – Asrar Qureshi’s Blog Post #1040

This blog post by Asrar Qureshi discusses the role of Contract Research Organizations (CROs) in pharmaceutical development, including their services like clinical trial management and regulatory support. It highlights challenges and evolving trends in the industry, such as technology integration and changing sponsor needs, emphasizing the importance of adaptation for CROs’ future success.
Share
View Post
  • 5 min

Long Live Every One !! – Asrar Qureshi’s Blog Post #1003

The longevity market is experiencing rapid growth driven by biotechnology, AI, and personalized medicine. It is anticipated to expand as consumers seek proactive health management and companies provide solutions for not only a longer life, but a healthier one. This shift focuses on delaying the aging process itself rather than treating age-related diseases.
Share